ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 110 filers reported holding ATHIRA PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,094 | -76.0% | 1,532 | -64.9% | 0.00% | – |
| Q2 2023 | $12,891 | +9816.2% | 4,370 | -91.6% | 0.00% | – |
| Q1 2023 | $130 | -21.7% | 52,068 | -0.4% | 0.00% | – |
| Q4 2022 | $166 | -99.9% | 52,254 | +3.6% | 0.00% | – |
| Q3 2022 | $150,000 | +4.2% | 50,455 | +6.6% | 0.00% | – |
| Q2 2022 | $144,000 | -73.6% | 47,313 | +17.2% | 0.00% | -100.0% |
| Q1 2022 | $545,000 | +1.5% | 40,371 | -2.1% | 0.00% | 0.0% |
| Q4 2021 | $537,000 | +37.0% | 41,235 | -1.3% | 0.00% | 0.0% |
| Q3 2021 | $392,000 | -4.9% | 41,760 | +3.7% | 0.00% | 0.0% |
| Q2 2021 | $412,000 | +90.7% | 40,260 | +242.2% | 0.00% | – |
| Q1 2021 | $216,000 | -40.5% | 11,766 | +11.0% | 0.00% | -100.0% |
| Q4 2020 | $363,000 | – | 10,598 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,691,623 | $57,938,000 | 8.52% |
| ACUTA CAPITAL PARTNERS, LLC | 393,000 | $13,460,000 | 3.66% |
| Logos Global Management LP | 947,873 | $32,465,000 | 2.78% |
| RTW INVESTMENTS, LP | 2,685,779 | $88,899,000 | 1.49% |
| Avidity Partners Management LP | 1,043,873 | $35,753,000 | 1.16% |
| Perceptive Advisors | 3,114,805 | $106,682,000 | 1.14% |
| Sofinnova Investments, Inc. | 509,168 | $17,439,000 | 1.04% |
| HighVista Strategies LLC | 32,062 | $1,098,000 | 0.70% |
| Rock Springs Capital Management LP | 860,902 | $29,486,000 | 0.62% |
| PFM Health Sciences, LP | 470,227 | $16,105,000 | 0.57% |